Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 1 9Phase 1/2 8Phase 3 3Phase NA 1Phase 4 1

Status

Unknown 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Leukemia, Myeloid, Acute 89Leukemia 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma 26Leukemia, Erythroblastic, Acute 19Leukemia, Myelomonocytic, Acute 18Leukemia, Monocytic, Acute 18Leukemia, Megakaryoblastic, Acute 18Congenital Abnormalities 13Burkitt Lymphoma 13Lymphoma, Large B-Cell, Diffuse 12Myelodysplastic Syndromes 10Lymphoma, Non-Hodgkin 10Anemia, Refractory, with Excess of Blasts 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma, Follicular 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Eosinophilic, Acute 6Recurrence 5Myeloproliferative Disorders 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Promyelocytic, Acute 5Leukemia, Biphenotypic, Acute 5Leukemia, Basophilic, Acute 5Hodgkin Disease 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Multiple Myeloma 4

Interventions

Rituximab 28Cyclophosphamide 14ibrutinib 10Vincristine 10Prednisone 10Doxorubicin 10Bendamustine Hydrochloride 9Radiotherapy 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6zanubrutinib 5acalabrutinib 4Lenalidomide 4Cyclosporine 4orelabrutinib 3Whole-Body Irradiation 3R-CHOP protocol 3Mycophenolic Acid 3Melphalan 3Interferon-alpha 3Etoposide 3Dexamethasone 3Cytarabine 3Cyclosporins 3venetoclax 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2VAP-cyclo protocol 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Mantle-Cell × Cytarabine × Clear all
NCT01449344 2017-03-07

(R-HAD)

European Mantle Cell Lymphoma Network

Phase 3 Unknown
128 enrolled
Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT00016887 2013-09-17

Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00209222 2012-09-10

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

European Mantle Cell Lymphoma Network

Phase 3 Unknown
360 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡